- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Glucose transporter 1 (SLC2A1), commonly known as GLUT1, is a facilitative glucose transporter responsible for basal glucose uptake in many tissues and plays a central role in cellular energy metabolism. GLUT1 Antibody Protein Microarray Validated (clone GLUT1/2475) recognizes the SLC2A1 protein and has undergone large-scale human protein microarray specificity testing to support selective detection of the GLUT1 glucose transporter. Protein microarray validation platforms enable antibody binding to be evaluated across thousands of full-length human proteins simultaneously, providing a proteome-wide assessment of antibody selectivity and helping confirm that the reagent preferentially recognizes its intended target protein.
GLUT1 is primarily localized to the plasma membrane where it mediates facilitated diffusion of glucose into cells, allowing tissues to maintain energy production through glycolysis and oxidative metabolism. Because glucose transport is essential for cellular energy balance, SLC2A1 expression is widely observed in tissues requiring constant glucose supply such as erythrocytes, endothelial cells, and metabolically active epithelial cell populations. Investigation of GLUT1 distribution therefore provides insight into cellular metabolism, glucose transport regulation, and membrane transporter biology.
In many tumor types, GLUT1 expression is frequently increased as part of metabolic reprogramming associated with rapid cell proliferation and adaptation to hypoxic microenvironments. Upregulation of SLC2A1 supports enhanced glucose uptake and glycolytic metabolism, which are characteristic features of many cancer cells. As a result, GLUT1 is widely studied in cancer metabolism research and is often evaluated when investigating metabolic signaling pathways and cellular responses to hypoxia or metabolic stress.
Protein microarray specificity validation provides an important layer of antibody characterization by testing binding interactions against thousands of proteins in parallel. In these large-scale microarray assays, antibodies are incubated with arrays containing extensive collections of full-length human proteins, allowing measurement of signal strength and assessment of relative target specificity. Strong preferential binding of clone GLUT1/2475 to SLC2A1 compared with other proteins supports the specificity of the antibody for detecting the GLUT1 glucose transporter.
GLUT1 Antibody Protein Microarray Validated (clone GLUT1/2475) therefore provides a research reagent supported by proteome-scale specificity testing. Protein microarray validation data strengthen confidence that the antibody selectively recognizes SLC2A1, supporting studies of glucose transporter expression, cellular metabolism, and metabolic adaptation in normal physiology and disease research.
Optimal dilution of the GLUT1 Antibody Protein Microarray Validated clone GLUT1/2475 should be determined by the researcher.
A portion of amino acids 203-305 from the human protein was used as the immunogen for this GLUT1 Antibody Protein Microarray Validated clone GLUT1/2475.
Store the GLUT1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
SLC2A1 antibody, Glucose transporter 1 antibody, GLUT-1 antibody, Erythrocyte glucose transporter antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.